Page last updated: 2024-11-08

chloramphenicol and Granulomatosis with Polyangiitis

chloramphenicol has been researched along with Granulomatosis with Polyangiitis in 1 studies

Amphenicol: Chloramphenicol and its derivatives.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anosova, RF1
Iazovitskaia, LM1

Other Studies

1 other study available for chloramphenicol and Granulomatosis with Polyangiitis

ArticleYear
[Long term follow-up and treatment of Wegener's granulomatosis].
    Vrachebnoe delo, 1976, Issue:10

    Topics: Adult; Chloramphenicol; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Male; Nandrolon

1976